• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法国遗传性出血性毛细血管扩张症中ALK1/ACVRL1和ENG基因的分子筛查

Molecular screening of ALK1/ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in France.

作者信息

Lesca Gaëtan, Plauchu Henri, Coulet Florence, Lefebvre Sylvain, Plessis Ghislaine, Odent Sylvie, Rivière Sophie, Leheup Bruno, Goizet Cyril, Carette Marie-France, Cordier Jean-François, Pinson Stéphane, Soubrier Florent, Calender Alain, Giraud Sophie

机构信息

Laboratoire de Génétique, Hôpital Edouard Herriot, Lyon, France.

出版信息

Hum Mutat. 2004 Apr;23(4):289-99. doi: 10.1002/humu.20017.

DOI:10.1002/humu.20017
PMID:15024723
Abstract

Hereditary hemmorrhagic telangiectasia (HHT, or Osler-Rendu-Weber syndrome) is an autosomal dominant disease characterized by arteriovenous malformations, affecting 1 out of 10,000 individuals in France. The disease is caused by mutations of two genes: ENG and ALK1 (ACVRL1). We screened the coding sequence of ENG and ALK1 in 160 unrelated French index cases. A germline mutation was identified in 100 individuals (62.5%). A total of 36 mutations were found in ENG, including three nonsense mutations, 19 small insertions/deletions leading to a frameshift, two inframe deletions, seven missense mutations, and five intronic or splice-site mutations. Of the 36 mutations, 33 were novel mutations. A total of 64 mutations were found in ALK1, including six nonsense mutations, 28 small insertions/deletions leading to a frameshift, one inframe deletion, 27 missense mutations, and two intronic or splice-site mutations. Of the 64 mutations, 27 were novel mutations. Mutations were found in most parts of the coding sequence for both genes, except ALK1 exon 5 and ENG exons 12 to 14. Missense mutations in ALK1 were more frequent in exons 7, 8, and 10. ENG cDNA was sequenced for three intronic mutations: c.689+2T>C produced an abnormal transcript excluding exon 5, c.1103+3_1103+8del activated a cryptic splice site 22 bp upstream, and c.1428G>A produced two abnormal transcripts, one including intron 11 and the other excluding exon 10. Although most of the mutations were private, some recurrent mutations in ALK1 were of particular interest. Mutation c.1112_1113dupG (p.Gly371fsX391) was found in 17 unrelated individuals sharing a common haplotype, strongly suggesting a founder effect related to the concentration of patients previously reported in a specific French region (Rhône-Alpes). Three missense mutations involved the same codon: c.1231C>T (p.Arg411Trp), c.1232G>C (p.Arg411Pro), and c.1232G>A (p.Arg411Gln) were found in seven, two, and one patients, respectively. Haplotype analysis was in favor of both a founder effect and a mutation hot-spot.

摘要

遗传性出血性毛细血管扩张症(HHT,又称奥斯勒-伦杜-韦伯综合征)是一种常染色体显性疾病,其特征为动静脉畸形,在法国每10000人中就有1人患病。该疾病由两个基因ENG和ALK1(ACVRL1)的突变引起。我们对160例无亲缘关系的法国索引病例的ENG和ALK1编码序列进行了筛查。在100名个体(62.5%)中鉴定出种系突变。ENG基因共发现36个突变,包括3个无义突变、19个导致移码的小插入/缺失、2个框内缺失、7个错义突变以及5个内含子或剪接位点突变。在这36个突变中,有33个是新突变。ALK1基因共发现64个突变,包括6个无义突变、28个导致移码的小插入/缺失、1个框内缺失、27个错义突变以及2个内含子或剪接位点突变。在这64个突变中,有27个是新突变。两个基因的编码序列大部分区域都发现了突变,但ALK1基因的第5外显子和ENG基因的第12至14外显子除外。ALK1基因的错义突变在第7、8和10外显子中更为常见。对ENG基因的三个内含子突变进行了cDNA测序:c.689+2T>C产生了一个不包括第5外显子的异常转录本,c.1103+3_1103+8del激活了上游22 bp处的一个隐蔽剪接位点,c.1428G>A产生了两个异常转录本,一个包括第11内含子另一个不包括第10外显子。虽然大多数突变是散发性的,但ALK1基因中的一些复发性突变特别令人关注。在17名共享一个常见单倍型的无亲缘关系个体中发现了突变c.1112_1113dupG(p.Gly371fsX391),这强烈表明存在与先前报道的法国特定地区(罗纳-阿尔卑斯)患者集中情况相关的奠基者效应。三个错义突变涉及同一个密码子:c.1231C>T(p.Arg411Trp)、c.1232G>C(p.Arg411Pro)和c.1232G>A(p.Arg411Gln)分别在7名、2名和1名患者中被发现。单倍型分析支持存在奠基者效应和突变热点。

相似文献

1
Molecular screening of ALK1/ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in France.法国遗传性出血性毛细血管扩张症中ALK1/ACVRL1和ENG基因的分子筛查
Hum Mutat. 2004 Apr;23(4):289-99. doi: 10.1002/humu.20017.
2
Hereditary hemorrhagic telangiectasia: ENG and ALK-1 mutations in Dutch patients.遗传性出血性毛细血管扩张症:荷兰患者中的ENG和ALK-1突变
Hum Genet. 2005 Jan;116(1-2):8-16. doi: 10.1007/s00439-004-1196-5. Epub 2004 Oct 23.
3
Distribution of ENG and ACVRL1 (ALK1) mutations in French HHT patients.法国遗传性出血性毛细血管扩张症(HHT)患者中ENG和ACVRL1(ALK1)突变的分布情况。
Hum Mutat. 2006 Jun;27(6):598. doi: 10.1002/humu.9421.
4
Mutation analysis in Norwegian families with hereditary hemorrhagic telangiectasia: founder mutations in ACVRL1.挪威遗传性出血性毛细血管扩张症家族的突变分析:ACVRL1中的奠基者突变
Clin Genet. 2016 Feb;89(2):182-6. doi: 10.1111/cge.12612. Epub 2015 Jun 5.
5
Hepatic manifestation is associated with ALK1 in hereditary hemorrhagic telangiectasia: identification of five novel ALK1 and one novel ENG mutations.遗传性出血性毛细血管扩张症中的肝脏表现与ALK1相关:鉴定出五个新的ALK1突变和一个新的ENG突变。
Hum Mutat. 2005 Mar;25(3):320. doi: 10.1002/humu.9311.
6
Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia and expression analysis of Endoglin and ALK1.西班牙遗传性出血性毛细血管扩张症患者的突变研究及内皮糖蛋白和激活素受体样激酶1的表达分析
Hum Mutat. 2006 Mar;27(3):295. doi: 10.1002/humu.9413.
7
Novel mutations and polymorphisms in genes causing hereditary hemorrhagic telangiectasia.导致遗传性出血性毛细血管扩张症的基因中的新型突变和多态性。
Hum Mutat. 2005 Mar;25(3):320-1. doi: 10.1002/humu.9312.
8
Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype.在对200名接受遗传性出血性毛细血管扩张症(HHT)临床基因检测的个体进行的研究中,发现ENG和ACVRL1基因的新突变:基因型与表型的相关性。
Hum Mutat. 2006 Jul;27(7):667-75. doi: 10.1002/humu.20342.
9
Mutation analysis in hereditary haemorrhagic telangiectasia in Germany reveals 11 novel ENG and 12 novel ACVRL1/ALK1 mutations.德国遗传性出血性毛细血管扩张症的突变分析揭示了11种新的ENG突变和12种新的ACVRL1/ALK1突变。
Clin Genet. 2006 Mar;69(3):239-45. doi: 10.1111/j.1399-0004.2006.00574.x.
10
DHPLC-based mutation analysis of ENG and ALK-1 genes in HHT Italian population.基于变性高效液相色谱法的意大利遗传性出血性毛细血管扩张症患者ENG和ALK-1基因突变分析
Hum Mutat. 2006 Feb;27(2):213-4. doi: 10.1002/humu.9400.

引用本文的文献

1
ALK1-BMPRII agonism by clustering bispecific antibodies treats hereditary hemorrhagic telangiectasia.通过双特异性抗体聚集实现的ALK1-BMPRII激动作用可治疗遗传性出血性毛细血管扩张症。
bioRxiv. 2025 Aug 14:2025.08.13.670104. doi: 10.1101/2025.08.13.670104.
2
Pathogenic Variant Frequencies in Hereditary Haemorrhagic Telangiectasia Support Clinical Evidence of Protection from Myocardial Infarction.遗传性出血性毛细血管扩张症的致病变异频率支持预防心肌梗死的临床证据。
J Clin Med. 2023 Dec 31;13(1):250. doi: 10.3390/jcm13010250.
3
Computational and Experimental Analyses for Pathogenicity Prediction of Missense Variants in Hereditary Hemorrhagic Telangiectasia.
遗传性出血性毛细血管扩张症错义变异致病性预测的计算与实验分析
J Clin Med. 2023 Jul 29;12(15):5002. doi: 10.3390/jcm12155002.
4
Improving Hereditary Hemorrhagic Telangiectasia Molecular Diagnosis: A Referral Center Experience.遗传性出血性毛细血管扩张症分子诊断的改进:一个转诊中心的经验。
Genes (Basel). 2023 Mar 22;14(3):772. doi: 10.3390/genes14030772.
5
Pulmonary Arteriovenous Malformation in a Rare Case of Hereditary Hemorrhagic Telangiectasia.遗传性出血性毛细血管扩张症罕见病例中的肺动静脉畸形
Cureus. 2022 Dec 9;14(12):e32365. doi: 10.7759/cureus.32365. eCollection 2022 Dec.
6
Combining genetic constraint with predictions of alternative splicing to prioritize deleterious splicing in rare disease studies.结合遗传约束和选择性剪接预测,优先考虑罕见病研究中的有害剪接。
BMC Bioinformatics. 2022 Nov 14;23(1):482. doi: 10.1186/s12859-022-05041-x.
7
Pulmonary Hypertension Associated Genetic Variants in Sarcoidosis Associated Pulmonary Hypertension.结节病相关肺动脉高压中的肺动脉高压相关基因变异
Diagnostics (Basel). 2022 Oct 21;12(10):2564. doi: 10.3390/diagnostics12102564.
8
An update on the ophthalmic features in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber syndrome).遗传性出血性毛细血管扩张症(Rendu-Osler-Weber 综合征)眼部特征的最新研究进展。
Int Ophthalmol. 2022 Jun;42(6):1987-1995. doi: 10.1007/s10792-021-02197-y. Epub 2022 Jan 16.
9
Current Status of Clinical and Genetic Screening of Hereditary Hemorrhagic Telangiectasia Families in Hungary.匈牙利遗传性出血性毛细血管扩张症家族的临床与基因筛查现状
J Clin Med. 2021 Aug 24;10(17):3774. doi: 10.3390/jcm10173774.
10
Genetic syndromes with vascular malformations - update on molecular background and diagnostics.伴有血管畸形的遗传综合征——分子背景与诊断的最新进展
Arch Med Sci. 2020 Feb 25;17(4):965-991. doi: 10.5114/aoms.2020.93260. eCollection 2021.